Sandborn, W. J., Panés, J., Panaccione, R., D’Haens, G., Sands, B. E., Su, C., . . . Chan, G. (2019). A202 TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 5.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS. J Can Assoc Gastroenterol.
استشهاد بنمط شيكاغوSandborn, W J., et al. "A202 TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 5.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS." J Can Assoc Gastroenterol 2019.
MLA استشهادSandborn, W J., et al. "A202 TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 5.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS." J Can Assoc Gastroenterol 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.